Michael Golembiewski

2022

In 2022, Michael Golembiewski earned a total compensation of $1.1M as Chief Financial Officer at Apricus Biosciences, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$126,850
Option Awards$616,800
Salary$317,125
Other$10,852
Total$1,071,627

Golembiewski received $616.8K in option awards, accounting for 58% of the total pay in 2022.

Golembiewski also received $126.9K in non-equity incentive plan, $317.1K in salary and $10.9K in other compensation.

Rankings

In 2022, Michael Golembiewski's compensation ranked 2,887th out of 5,756 executives tracked by ExecPay. In other words, Golembiewski earned more than 49.8% of executives.

ClassificationRankingPercentile
All
2,887
out of 5,756
50th
Division
Manufacturing
1,611
out of 3,133
49th
Major group
Chemicals And Allied Products
748
out of 1,419
47th
Industry group
Drugs
698
out of 1,320
47th
Industry
Pharmaceutical Preparations
506
out of 966
48th
Source: SEC filing on April 12, 2023.

Golembiewski's colleagues

We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2022.

2022

Raj Mehra

Apricus Biosciences

Chief Executive Officer

News

In-depth

You may also like